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OBJECTIVES: To achieve a polio-free certification in Iran, a nationwide active surveillance program for acute 
flaccid paralysis (AFP) was set up following World Health Organization guidelines. This article describes the re-
sults of an eight-year surveillance of AFP in Hamadan, in the west of Iran.
METHODS: A standard set of minimum core variables were collected. All cases of non-polio AFP in children 
aged <15 years old were reported. Two stool specimens were collected within 14 days of the onset of paraly-
sis.
RESULTS: During the eight-year survey, 88 AFP cases aged <15 years old were reported. About 40% (35/88) 
of cases were aged ≤5 years, 56% (49/88) were boys, 19 (21.6%) had fever at the onset of paralysis, 74 (84.0%) 
had complete paralysis within four days of onset, and 22 (24.7%) had asymmetric paralysis. More than one 
AFP case was detected per 100,000 children aged <15 years old in all years. The risk of AFP in patients aged 
<5 years old was almost double that of older patients. Guillain-Barré Syndrome was the major leading cause 
of AFP (66/88). Adequate stool specimens were collected from 85% of AFP patients. All stool specimens were 
tested virologically, but no wild polioviruses were detected.
CONCLUSION: The active surveillance of non-polio AFP was efficient over the last eight years and exceeded 
1.0 case per 100,000 children aged <15 years old. Nonetheless, there was a decreasing trend in the detection 
of AFP cases during the last two years and should be the focus of the policymakers’ special attention, although 
AFP cases were still above the target level.
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INTRODUCTION
Acute flaccid paralysis (AFP) is often used to describe a sud-
den onset of flaccid paralysis in one or more limbs in a child 
aged <15 years old, as might be found with poliomyelitis or 
other neurologic disorders. Poliomyelitis is an acute viral infec-
tion, which can spread directly or indirectly from person to per-
son. The characteristics of this infectious disease range in severi-
ty from a non-specific illness to severe flaccid paralysis with per-
manent disability [1].
In 1998, the World Health Assembly (WHA), which is the di-
recting council of the World Health Organization (WHO), es-
tablished the target of global polio eradication by the end of 
2000 [2]. Four principal strategies were developed for polio 
eradication, which were proven effective in many countries in-
cluding (a) high immunization coverage with at least three dos-
es of oral polio vaccine (OPV) in infants aged <1 year; (b) sup-
plemental doses of OPV during national immunization days; (c) 
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mopping-up vaccination in areas or among populations at high 
risk of poliovirus transmission; and (d) sensitive surveillance and 
investigation of AFP [3]. Since 1988, the WHA has declared that 
the “number of countries where polio was endemic decreased 
from approximately 125 to 6 by the end of 2003” [4].
AFP cases with fever at the onset of paralysis, age <5 years, 
and asymmetrical paralysis who are unvaccinated are suspected 
poliomyelitis cases and should be prioritized for investigation 
[5]. Two key performance indicators are monitored for AFP sur-
veillance: 1) detection of all cases of AFP in children aged <15 
years old (target: ≥1 case of non-polio AFP detected annually 
per 100,000 population aged <15 years old); 2) adequate col-
lection of two stool specimens within 14 days of the onset of 
paralysis (target: >80% of AFP cases have adequate stool spec-
imens) [6]. AFP surveillance is a 100% sensitive system with 
poor specificity [7].
The last case of poliomyelitis occurred in Iran due to indige-
nous transmission of wild poliovirus in 2000. To achieve a po-
lio-free certification in Iran, a nationwide active surveillance 
program for AFP was set up in the population aged <15 years 
old following WHO guidelines [8]. The surveillance of AFP be-
gan in 1998 under the supervision of the Ministry of Health 
and Medical Education (MOHME) and continued towards the 
WHO targets for AFP detection and adequate stool sample col-
lection. This article describes the results of an eight-year surveil-
lance of AFP in Hamadan, in the west of Iran, during the post-
polio-free phase and explains the progress made toward polio 
eradication from 2002-2009.
MATERIALS AND METHODS
This study reports the results of a surveillance system for non-
polio AFP that was conducted according to the WHO recommen-
dations for global eradication of poliomyelitis. In 1998, an ac-
tive surveillance program for non-polio AFP was set up by the 
Iranian MOHME according to WHO guidelines using the same 
strategy throughout the country. All medical universities affiliat-
ed the MOHME, including Hamadan University of Medical Sci-
ences, participated in this national survey. Hamadan province is 
located in the north-west of Iran (Figure 1). According to the 
survey in 2006, the population of this province was 1,703,267 
(2.4% of the total population of Iran) [9].
Based on WHO guidelines, a standard set of minimum core 
variables that are essential to track the circulation of wild polio-
virus, manage national programs and monitor AFP surveillance 
performance were collected. Three pieces of clinical information 
were collected from each AFP case and recorded: (a) fever at the 
onset of paralysis (Yes/No); (b) complete paralysis within four 
days of onset (Yes/No); and (c) asymmetric paralysis (Yes/No).
All patients with AFP aged <15 years old were detected and 
reported by phone as soon as possible. All AFP cases considered 
suspected poliomyelitis and were followed for further evalua-
tion. Two stool specimens or two rectal swab specimens were 
obtained 24 hours apart from patients during the first 14 days 
after the onset of paralytic disease. All stool specimens from 
AFP cases were processed in a WHO-accredited laboratory lo-
cated in the School of Public Health, Tehran University of Med-
ical Sciences. Virus isolation and typing were performed accord-
ing to WHO recommended standard methods [10]. AFP cases 
with inadequate stool specimens were followed up for 60 days. 
A national expert committee reviewed AFP cases which were 
clinically compatible with polio with residual paralysis at 60 days 
and from whom no stool specimens were available or from whom 
there were negative or inadequate specimens. 
The detected cases were divided into three different age groups 
including <5, 5 to 9, and 10 to 14 years old. Then, in order to 
estimate the mean annual incidence rate of non-polio AFP per 
100,000 population aged <15 years old, the cases of each age 
group were considered as the nominator and the relevant pop-
ulation as the denominator using the Poisson regression model. 
Poisson regression analysis was performed at a 95% significant 
level using the statistical software Stata version 10 (StataCorp, 
College Station, TX, USA).
RESULTS
During the eight-year survey, from 2002 to 2009, 88 AFP 
Figure 1. Geographical location of Hamadan province in the Islam-
ic Republic of Iran.3
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cases were reported. The patients were aged <15 years with a 
mean age of 6.8 years. About 40% (35/88) of AFP cases aged 
≤5 years, 56% (49/88) were boys, and 24% (21/88) were re-
ported in 2007 (Table 1).
Of the 88 AFP cases, 19 (21.6%) had fever at the onset of 
paralysis, 74 (84.0%) had complete paralysis within four days 
of onset, and 22 (24.7%) had asymmetric paralysis.
According to the Poisson regression analysis, the risk of AFP 
in patients aged <5 years old was almost double that of pati-
ents aged 5-9 and 10-14 years old (p=0.030 and p=0.012, re-
spectively). However, there was no statistically significant differ-
ences between the risk of AFP among girls and boys (p=0.414) 
(Table 2). 
The results of a complete virologic investigation of AFP cases 
from 2002 to 2009 are presented in Figure 2. According to these 
findings, the surveillance system could achieve and even ex-
ceed the expected minimum level defined by WHO as the tar-
get of detecting more than one non-polio AFP case per 100,000 
population aged <15 years old in all years.
Data on the differential diagnosis of AFP are presented in Fig-
ure 3. Guillain-Barré syndrome was among the major leading 
cause of AFP (66 out of 88 cases). Eight (9%) AFP cases were 
categorized as “others” including transverse myelitis, multiple 
sclerosis, nerve lesions, epilepsy, acute viral infection, and cere-
brospinal tumors. The final clinical diagnosis was not reported 
for 14 (16%) cases, although laboratory findings refuted the 
probability of poliomyelitis. 
The information on the percentage of AFP cases with two ad-
equate stool specimens is presented in Figure 4. Accordingly, at 
least two stool specimens or rectal swab specimens were col-
Table 1. Distribution of non-polio acute flaccid paralysis by year, sex and age group
Year
Male Female Both
<5 5-9 10-14 Total <5 5-9 10-14 Total <5 5-9 10-14 Total
2002 3 1 0 4 1 0 2 3 4 1 2 7
2003 3 1 1 5 0 1 2 3 3 2 3 8
2004 3 1 2 6 2 0 2 4 5 1 4 10
2005 3 2 2 7 0 4 1 5 3 6 3 12
2006 1 1 2 4 3 1 1 5 4 2 3 9
2007 5 4 2 11 4 2 4 10 9 6 6 21
2008 5 2 2 9 1 1 3 5 6 3 5 14
2009 0 1 2 3 1 0 3 4 1 1 5 7
Total 23 13 13 49 12 9 18 39 35 22 31 88
Table 2. Mean annual incidence rate of non-polio acute flaccid paralysis (AFP) per 100,000 under 15 years old children by age and sex us-
ing Poisson regression analysis
Variable Population Non-polio AFP
Mean annual incidence rate 
per 100,000*
Relative risk 95% CI p-value
Age (yr)
<5 986,426 35 3.55 1.00 - -
5-9 1,120,311 22 1.96 0.55 0.32, 0.94 0.030
10-14 1,618,607 31 1.92 0.54 0.33, 0.88 0.012
Sex
Female 1,813,246 39 2.15 1.00 - -
Male 1,912,098 49 2.56 1.19 0.78, 1.81 0.414
CI, confidence interval.
*In order to estimate the mean annual incidence rate of non-polio AFP per 100,000 population aged <15 years old, the cases of each age group were con-
sidered as the nominator and the relevant population as the denominator.
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Figure 2. Annual incidence rate of non-polio AFP per 100,000 pop-
ulation aged <15 years old in Hamadan, Iran (2002 to 2009).
AFP, acute flaccid paralysis.
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lected from all patients. The two stool specimens were obtained 
1-5 days apart (1.2 days on average). The specimens of almost 
85% (75) of the cases were collected during the first or second 
week after the onset of paralytic disease and the others were 
collected during the third week. All stool specimens were tested 
virologically, but no wild polioviruses were detected.
DISCUSSION
The present study represents a comprehensive province-based 
survey of non-polio AFP in Iran, which reports the results of an 
eight-year AFP surveillance program in Hamadan province, in 
the west of Iran, from 2002 to 2009. There is a nationwide heal-
th network in Iran, which covers all parts of the county, even 
small, remote villages. It is obligatory for all health workers 
throu  ghout the country to report and follow up any cases of 
AFP. With such a widespread and consolidated health system, it 
is rare that a case of AFP is missed. 
Detecting and investigating all cases of non-polio AFP in the 
population <15 years old are among the most criteria for po-
liomyelitis-free certification. In polio-free regions, the incidence 
of AFP is expected to be at least one or more per 100,000 chil-
dren aged <15 years old [6]. The results of this study indicated 
that active surveillance of AFP was efficient over the past eight 
consecutive years and even exceeded the WHO-established mi-
nimum non-polio AFP rate. In addition, the second criteria of 
AFP surveillance, adequate collection of two stool specimens 
within 14 days of the onset of paralysis in at least 80% of de-
tected AFP cases [6], was achieved efficiently as well.
National surveys in Pakistan and Afghanistan have reported 
relatively higher AFP rates compared to the results of present 
study, but a lower percentage of adequate stool specimens. Ac-
cordingly, non-polio AFP rate for Pakistan in 2003 was 3.0 per 
100,000 children aged <15 years old. The percentage of AFP 
cases with adequate stool specimens was 89% and 90% in 2003 
and 2004, respectively. Non-polio AFP rates in Afghanistan were 
4.0 per 100,000 in children aged <15 years old in 2003 and 4.2 
in 2004. The percentage of patients with adequate stool speci-
mens was 88% in 2003 and 93% in 2004 [11].
Detection and investigation of AFP cases increased over time 
from 2002 to 2007, but decreased thereafter. This may be a se-
rious alarm for the AFP surveillance system, particularly if this 
decreasing trend continues in subsequent years. Although AFP 
cases were above the target level, this concern should be the fo-
cus of policymakers’ special attention.
The frequency of AFP was higher among boys than among 
girls (49 versus 39, respectively); nonetheless, the mean annual 
incidence rate of AFP per 100,000 boys and girls was not statis-
tically significant (p=0.414). D’Errico et al. conducted a survey 
in Italy and reported 15 AFP cases among boys compared to 12 
AFP cases among girls [10]. Oostvogel et al. [12] in the Nether-
lands reported 34 AFP cases in boys in comparison with 18 AFP 
cases in girls.
Guillain-Barré syndrome is known as the major cause of non-
polio AFP, particularly after the global eradication of poliomy-
elitis [13]. This syndrome was the most common cause of non-
polio AFP cases and comprised 75% of all causes of AFP cases 
in the present study. A study conducted by Davarpanah et al. in 
2008 [14] in Shiraz province, in central Iran, reported a similar 
result. They indicated that Guillain-Barré Syndrome was the 
main leading cause of AFP in 66% of the patients.
As mentioned in the introduction section, to achieve polio-
free certification in Iran, a nationwide active surveillance pro-
gram for AFP was set up simultaneously with same methods 
14 (16%)
8 (9%)
66 (75%)
Guillain barre Others* Not reported
Figure 3. Differential diagnosis of non-polio acute flaccid paralysis 
among the population aged <15 years old in Hamadan, Iran (2002 
to 2009).
*others includes transverse myelitis, multiple sclerosis, nerve le-
sions, epilepsy, acute viral infection, and cerebrospinal tumor.
Figure 4. Percent of non-polio acute flaccid paralysis cases among 
the population aged <15 years old whose stool specimens were 
collected during the first or second week after the onset of paralytic 
disease in Hamadan, Iran (2002 to 2009).
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for the target population in all provinces of Iran following WHO 
guidelines. The surveillance of AFP began in 1998 under the 
supervision of the Ministry of Health and Medical Education 
and continued towards the WHO targets for AFP detection and 
adequate stool sample collection. This paper is part of the re-
sults of this nationwide surveillance of non-polio AFP. In addi-
tion, Hamadan is not a border province and hence cross-border 
population movements are rare if they occur at all. Accordingly, 
it is expected that this survey may represent the profile of the 
national survey in Iran over the last eight years and its results 
may be generalized to the vast majority or at least most parts 
of the country, although diversity between different provinces 
is possible.
This study had a number of limitations. First, the data on AFP 
cases reported from 2002 to 2006 were disorganized, incom-
plete, and illegible and hence had to be compared with the data 
recorded based on telephone reports. Second, the final clinical 
diagnosis of 14 AFP cases was not recorded. Furthermore, the 
results of the decision made by the national expert committee 
who reviewed AFP cases which were clinically compatible with 
polio with residual paralysis at 60 days were not recorded for a 
number of patients.
Despite its limitations, the current study may have a number 
of implications on health care policy. First, the performance of 
the non-polio AFP surveillance program was evaluated in the 
target population for eight consecutive years. Second, the asso-
ciation between male gender and AFP was clearly indicated. 
Furthermore, Guillain-Barré Syndrome was found to be the 
main cause of AFP among children aged <15 years old.
The results of this survey indicate that the active surveillance 
of non-polio AFP was efficient over the past eight years and ex-
ceeded 1.0 case per 100,000 children aged <15 years old, the 
WHO-established minimum non-polio AFP rate. Furthermore, 
the percentage of patients with AFP from whom adequate stool 
specimens were collected was above the minimum target level 
of 80%. Nonetheless, there was decreasing trend in the detec-
tion of AFP cases over the last two years, although AFP case 
numbers were still above the target level. However, this trend 
may continue in subsequent years and should be the focus of 
policymakers’ special attention. We also found Guillain-Barré 
Syndrome was the most common cause of non-polio AFP cas-
es, particularly in boys. 
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